Crossmark Global Holdings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53M | Sell |
44,150
-677
| -2% | -$692K | 0.69% | 26 |
|
|
2026
Q1 | $41.2M | Buy |
44,827
+8,318
| +23% | +$8.43M | 0.61% | 28 |
|
|
2025
Q4 | $39.2M | Buy |
36,509
+3,821
| +12% | +$3.65M | 0.56% | 32 |
|
|
2025
Q3 | $24.9M | Sell |
32,688
-1,008
| -3% | -$750K | 0.37% | 58 |
|
|
2025
Q2 | $26.3M | Buy |
33,696
+5,980
| +22% | +$4.65M | 0.42% | 49 |
|
|
2025
Q1 | $22.9M | Buy |
27,716
+393
| +1% | +$327K | 0.4% | 51 |
|
|
2024
Q4 | $21.1M | Sell |
27,323
-8,787
| -24% | -$7.28M | 0.38% | 54 |
|
|
2024
Q3 | $32M | Sell |
36,110
-993
| -3% | -$893K | 0.57% | 30 |
|
|
2024
Q2 | $33.6M | Buy |
37,103
+593
| +2% | +$474K | 0.64% | 21 |
|
|
2024
Q1 | $28.4M | Sell |
36,510
-612
| -2% | -$436K | 0.54% | 27 |
|
|
2023
Q4 | $21.6M | Sell |
37,122
-1,602
| -4% | -$935K | 0.45% | 41 |
|
|
2023
Q3 | $22.4M | Sell |
38,724
-370
| -0.9% | -$191K | 0.51% | 35 |
|
|
2023
Q2 | $17.9M | Buy |
39,094
+601
| +2% | +$252K | 0.39% | 53 |
|
|
2023
Q1 | $13.2M | Sell |
38,493
-15,839
| -29% | -$5.34M | 0.31% | 73 |
|
|
2022
Q4 | $19.9M | Sell |
54,332
-6,620
| -11% | -$2.35M | 0.5% | 32 |
|
|
2022
Q3 | $19.7M | Sell |
60,952
-735
| -1% | -$233K | 0.55% | 28 |
|
|
2022
Q2 | $20M | Buy |
61,687
+3,045
| +5% | +$914K | 0.52% | 31 |
|
|
2022
Q1 | $16.8M | Sell |
58,642
-259
| -0.4% | -$66.7K | 0.37% | 54 |
|
|
2021
Q4 | $16.3M | Sell |
58,901
-87,108
| -60% | -$22.1M | 0.35% | 61 |
|
|
2021
Q3 | $33.7M | Buy |
146,009
+1,010
| +0.7% | +$249K | 0.79% | 16 |
|
|
2021
Q2 | $33.3M | Buy |
144,999
+395
| +0.3% | +$79.3K | 0.78% | 14 |
|
|
2021
Q1 | $27M | Sell |
144,604
-8,078
| -5% | -$1.58M | 0.67% | 20 |
|
|
2020
Q4 | $25.8M | Buy |
152,682
+74,857
| +96% | +$11.2M | 0.65% | 22 |
|
|
2020
Q3 | $11.5M | Sell |
77,825
-290
| -0.4% | -$44.9K | 0.32% | 70 |
|
|
2020
Q2 | $12.8M | Buy |
78,115
+1,572
| +2% | +$241K | 0.37% | 58 |
|
|
2020
Q1 | $10.6M | Sell |
76,543
-4,783
| -6% | -$657K | 0.38% | 58 |
|
|
2019
Q4 | $10.7M | Sell |
81,326
-10,283
| -11% | -$1.19M | 0.29% | 93 |
|
|
2019
Q3 | $10.2M | Sell |
91,609
-2,941
| -3% | -$327K | 0.3% | 86 |
|
|
2019
Q2 | $10.5M | Sell |
94,550
-7,959
| -8% | -$937K | 0.29% | 80 |
|
|
2019
Q1 | $13.3M | Sell |
102,509
-3,735
| -4% | -$454K | 0.38% | 54 |
|
|
2018
Q4 | $12.3M | Buy |
106,244
+4,427
| +4% | +$495K | 0.38% | 56 |
|
|
2018
Q3 | $10.9M | Sell |
101,817
-4,222
| -4% | -$422K | 0.28% | 86 |
|
|
2018
Q2 | $9.05M | Sell |
106,039
-4,698
| -4% | -$386K | 0.24% | 100 |
|
|
2018
Q1 | $8.57M | Sell |
110,737
-558
| -0.5% | -$44.9K | 0.22% | 115 |
|
|
2017
Q4 | $9.4M | Buy |
111,295
+8,112
| +8% | +$690K | 0.23% | 107 |
|
|
2017
Q3 | $8.83M | Buy |
+103,183
| New | +$8.46M | 0.23% | 107 |
|
|
2016
Q3 | $8.83M | Buy |
+103,183
| New | +$8.26M | 0.23% | 107 |
|
Other funds holding LLY
SC
ONB
GIM
Crossmark Global Holdings's LLY Position: Q2 2026 in Review
Crossmark Global Holdings reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $692K and leaving 44,150 shares worth $53M. The position accounts for 0.69% of the portfolio, ranked #26.
Crossmark Global Holdings first reported a position in LLY in Q3 2016 and has held it in 37 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Crossmark Global Holdings held 44,150 shares of Eli Lilly worth $53M as of Q2 2026.
- Crossmark Global Holdings sold 677 Eli Lilly shares in Q2 2026, an estimated $692K.
- Eli Lilly made up 0.69% of Crossmark Global Holdings's portfolio in Q2 2026, its #26 holding.
- Crossmark Global Holdings first reported a position in Eli Lilly in Q3 2016 and has held it in 37 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.